Cargando…
Targeting glucose metabolism for cancer therapy
Cellular transformation is associated with the reprogramming of cellular pathways that control proliferation, survival, and metabolism. Among the metabolic changes exhibited by tumor cells is an increase in glucose metabolism and glucose dependence. It has been hypothesized that targeting glucose me...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280882/ https://www.ncbi.nlm.nih.gov/pubmed/22330683 http://dx.doi.org/10.1084/jem.20120162 |
_version_ | 1782223879062683648 |
---|---|
author | Hamanaka, Robert B. Chandel, Navdeep S. |
author_facet | Hamanaka, Robert B. Chandel, Navdeep S. |
author_sort | Hamanaka, Robert B. |
collection | PubMed |
description | Cellular transformation is associated with the reprogramming of cellular pathways that control proliferation, survival, and metabolism. Among the metabolic changes exhibited by tumor cells is an increase in glucose metabolism and glucose dependence. It has been hypothesized that targeting glucose metabolism may provide a selective mechanism by which to kill cancer cells. In this minireview, we discuss the benefits that high levels of glycolysis provide for tumor cells, as well as several key enzymes required by cancer cells to maintain this high level of glucose metabolism. It is anticipated that understanding which metabolic enzymes are particularly critical for tumor cell proliferation and survival will identify novel therapeutic targets. |
format | Online Article Text |
id | pubmed-3280882 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-32808822012-08-13 Targeting glucose metabolism for cancer therapy Hamanaka, Robert B. Chandel, Navdeep S. J Exp Med Minireview Cellular transformation is associated with the reprogramming of cellular pathways that control proliferation, survival, and metabolism. Among the metabolic changes exhibited by tumor cells is an increase in glucose metabolism and glucose dependence. It has been hypothesized that targeting glucose metabolism may provide a selective mechanism by which to kill cancer cells. In this minireview, we discuss the benefits that high levels of glycolysis provide for tumor cells, as well as several key enzymes required by cancer cells to maintain this high level of glucose metabolism. It is anticipated that understanding which metabolic enzymes are particularly critical for tumor cell proliferation and survival will identify novel therapeutic targets. The Rockefeller University Press 2012-02-13 /pmc/articles/PMC3280882/ /pubmed/22330683 http://dx.doi.org/10.1084/jem.20120162 Text en © 2012 Hamanaka and Chandel This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/). |
spellingShingle | Minireview Hamanaka, Robert B. Chandel, Navdeep S. Targeting glucose metabolism for cancer therapy |
title | Targeting glucose metabolism for cancer therapy |
title_full | Targeting glucose metabolism for cancer therapy |
title_fullStr | Targeting glucose metabolism for cancer therapy |
title_full_unstemmed | Targeting glucose metabolism for cancer therapy |
title_short | Targeting glucose metabolism for cancer therapy |
title_sort | targeting glucose metabolism for cancer therapy |
topic | Minireview |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280882/ https://www.ncbi.nlm.nih.gov/pubmed/22330683 http://dx.doi.org/10.1084/jem.20120162 |
work_keys_str_mv | AT hamanakarobertb targetingglucosemetabolismforcancertherapy AT chandelnavdeeps targetingglucosemetabolismforcancertherapy |